drugMR: A multi-omics pipeline for genetically anchored drug-target discovery
Motivation: Genetically supported drug targets are an estimated 2.6 times more likely to succeed clinically, yet a disease association alone does not show which protein to target, in which direction, or what other effects may follow. This currently requires chaining separate tools. Results: drugMR is a Nextflow pipeline that, from GWAS and pQTL summary statistics, runs cis-Mendelian…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
